Compare KOP & EVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KOP | EVH |
|---|---|---|
| Founded | 1988 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Forest Products | Other Consumer Services |
| Sector | Basic Materials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 536.4M | 468.7M |
| IPO Year | 2006 | 2015 |
| Metric | KOP | EVH |
|---|---|---|
| Price | $29.15 | $3.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 14 |
| Target Price | ★ $52.50 | $11.93 |
| AVG Volume (30 Days) | 136.6K | ★ 2.7M |
| Earning Date | 02-26-2026 | 02-19-2026 |
| Dividend Yield | ★ 1.10% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.78 | N/A |
| Revenue | $1,923,600,000.00 | ★ $2,054,052,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.94 | $26.87 |
| P/E Ratio | $37.10 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $22.99 | $3.50 |
| 52 Week High | $35.61 | $12.07 |
| Indicator | KOP | EVH |
|---|---|---|
| Relative Strength Index (RSI) | 59.00 | 32.71 |
| Support Level | $28.67 | $3.96 |
| Resistance Level | $29.91 | $4.26 |
| Average True Range (ATR) | 0.94 | 0.18 |
| MACD | 0.26 | 0.01 |
| Stochastic Oscillator | 75.81 | 2.75 |
Koppers Holdings Inc through its subsidiaries, manufactures and sells wood products, wood treatment chemicals, and carbon compounds used in markets such as railroad, aluminum and steel, agriculture, utilities, and residential lumber. The company is organized into three business segments: railroad and utility products and services, performance chemicals, and carbon materials and chemicals. Its product portfolio includes treated and untreated wood products like crossties used in railroads, wood preservation chemicals, and carbon compounds such as creosote used in the treatment of wood crossties, among others. The majority of its revenue comes from the company's railroad and utility products and services segment, and more than half of the company's revenue is earned in the United States.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.